retatrutide triple hormone receptor agonist obesity meets primary endpoints in two phase III trials, reporting up to 22.6% weight loss – touchENDOCRINOLOGY retatrutide mechanism of action triple
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26






























